These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 9258954
1. Endometrial carcinomas--flow cytometric DNA content and S-phase values. Jacobsen M, Jakobsen A, Nedergaard L, Andersen JE, Nielsen K. Pathol Res Pract; 1997; 193(4):283-90. PubMed ID: 9258954 [Abstract] [Full Text] [Related]
2. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma. Nola M, Jukić S, Ilić-Forko J, Babić D, Uzarević B, Petrovecki M, Suchanek E, Skrablin S, Dotlić S, Marusić M. Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103 [Abstract] [Full Text] [Related]
3. [Cytophotometric studies for evaluating the prognosis in endometrial cancer]. Köhler U, Krug H, Taubert G. Zentralbl Gynakol; 1991 Mar; 113(24):1371-9. PubMed ID: 1808964 [Abstract] [Full Text] [Related]
4. Prognostic significance of flow cytometric and clinical variables in endometrial adenocarcinoma stages I and II. Wagenius G, Bergström R, Strang P, Gerdes U, Rogo K, Tribukait B, Stendahl U. Anticancer Res; 1992 Mar; 12(3):725-32. PubMed ID: 1622130 [Abstract] [Full Text] [Related]
5. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma. Alektiar KM, McKee A, Lin O, Venkatraman E, Zelefsky MJ, Mychalczak BR, McKee B, Hoskins WJ, Barakat RR. Cancer; 2002 Jul 15; 95(2):316-21. PubMed ID: 12124832 [Abstract] [Full Text] [Related]
6. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma. Ismiil ND, Rasty G, Ghorab Z, Nofech-Mozes S, Bernardini M, Thomas G, Ackerman I, Covens A, Khalifa MA. Int J Gynecol Pathol; 2007 Jul 15; 26(3):278-83. PubMed ID: 17581412 [Abstract] [Full Text] [Related]
7. [A study on DNA content and cell cycle phase analysis in endometrial carcinoma]. Xue F, Jiao S, Zhao F. Zhonghua Fu Chan Ke Za Zhi; 1996 Apr 15; 31(4):216-9. PubMed ID: 8758776 [Abstract] [Full Text] [Related]
8. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion. Ismiil N, Rasty G, Ghorab Z, Nofech-Mozes S, Bernardini M, Ackerman I, Thomas G, Covens A, Khalifa MA. Ann Diagn Pathol; 2007 Aug 15; 11(4):252-7. PubMed ID: 17630108 [Abstract] [Full Text] [Related]
9. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Cirisano FD, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL. Gynecol Oncol; 2000 Apr 15; 77(1):55-65. PubMed ID: 10739691 [Abstract] [Full Text] [Related]
10. DNA content as a prognostic factor in endometrial carcinoma. Newbury R, Schuerch C, Goodspeed N, Fanning J, Glidewell O, Evans M. Obstet Gynecol; 1990 Aug 15; 76(2):251-7. PubMed ID: 2371030 [Abstract] [Full Text] [Related]
11. DNA ploidy is an independent prognostic indicator of overall survival in stage I endometrial endometrioid carcinoma. Santala M, Talvensaari-Mattila A. Anticancer Res; 2003 Aug 15; 23(6D):5191-6. PubMed ID: 14981988 [Abstract] [Full Text] [Related]
12. Role of DNA ploidy analysis in endometrial adenocarcinoma. Jhala DN, Atkinson BF, Balsara GR, Hernandez E, Jhala NC. Ann Diagn Pathol; 2001 Oct 15; 5(5):267-73. PubMed ID: 11598854 [Abstract] [Full Text] [Related]
13. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma. Baak JP, Snijders W, van Diermen B, van Diest PJ, Diepenhorst FW, Benraadt J. J Clin Oncol; 2003 Nov 15; 21(22):4214-21. PubMed ID: 14615450 [Abstract] [Full Text] [Related]
14. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma. Pfisterer J, Kommoss F, Sauerbrei W, Rendl I, Kiechle M, Kleine W, Pfleiderer A. Gynecol Oncol; 1995 Aug 15; 58(2):149-56. PubMed ID: 7622098 [Abstract] [Full Text] [Related]
15. Residual myometrial invasion after intracavitary irradiation of endometrial adenocarcinoma stages I and II. Relations to DNA content and S-phase rate. Wagenius G, Strang P, Boman K, Tribukait B, Stendahl U. In Vivo; 1988 Aug 15; 2(3-4):243-5. PubMed ID: 2979839 [Abstract] [Full Text] [Related]
16. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors]. Shimizu K. Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr 15; 47(4):413-8. PubMed ID: 7730696 [Abstract] [Full Text] [Related]
17. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. Gadducci A, Cosio S, Fanucchi A, Cristofani R, Genazzani AR. Anticancer Res; 2000 Apr 15; 20(3B):1977-84. PubMed ID: 10928137 [Abstract] [Full Text] [Related]
18. Predictive value of cell kinetics in endometrial adenocarcinoma. Mariani L, Conti L, Antenucci A, Vercillo M, Atlante M, Gandolfo GM. Anticancer Res; 2000 Apr 15; 20(5B):3569-74. PubMed ID: 11131664 [Abstract] [Full Text] [Related]
19. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. Orezzoli JP, Sioletic S, Olawaiye A, Oliva E, del Carmen MG. Gynecol Oncol; 2009 Jun 15; 113(3):316-23. PubMed ID: 19345400 [Abstract] [Full Text] [Related]
20. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma. Cirisano FD, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL. Gynecol Oncol; 1999 Sep 15; 74(3):385-94. PubMed ID: 10479498 [Abstract] [Full Text] [Related] Page: [Next] [New Search]